Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
Therapeutische Umschau. Revue Therapeutique|October 3, 2012
[Lung cancer - on the way to a molecular classification]S Savic, O GautschiTherapeutische Umschau. Revue Therapeutique|July 4, 2012
[Chemotherapy for malignant tumors of lung and pleura]S Rothschild, O GautschiTherapeutische Umschau. Revue Therapeutique|July 16, 2004
[Molecular therapy in lung cancer]O Gautschi, D C BetticherMedizinische Klinik, Intensivmedizin Und Notfallmedizin|April 25, 2022
[Oncological emergencies with special consideration of the side effects of checkpoint inhibitors]P Niederberger, M Christ, O GautschiRespiration; International Review of Thoracic Diseases|September 27, 2003
Acute respiratory failure and cerebral hemorrhage due to primary Epstein-Barr virus infectionO Gautschi, C Berger, J Gubler, et al.European Journal of Haematology|February 14, 2004
Successful treatment of chemotherapy-refractory Sézary syndrome with alemtuzumab (Campath-1H)O Gautschi, N Blumenthal, M Streit, et al.British Journal of Haematology|September 1, 2001
Persistent polyclonal B-cell lymphocytosis is an expansion of functional IgD(+)CD27(+) memory B cellsA Himmelmann, O Gautschi, M Nawrath, et al.Oncogene|January 18, 2012
MicroRNA-29b is involved in the Src-ID1 signaling pathway and is dysregulated in human lung adenocarcinomaS I Rothschild, M P Tschan, E A Federzoni, et al.ESMO Real World Data and Digital Oncology|February 6, 2026
Prevalence of functional iron deficiency in patients with malignancies and its impact on fatigue-specific quality of lifeS Zimmermann, S Aebi, O Gautschi, et al.ESMO Real World Data and Digital Oncology|April 3, 2026
Corrigendum to "Prevalence of functional iron deficiency in patients with malignancies and its impact on fatigue-specific quality of life": ESMO Real World Data And Digital Oncology, volume 8 (2025), 100140S Zimmermann, S Aebi, O Gautschi, et al.Pageof 3